>I think there is a good (50/50+) chance we see Roche initiate a study of some sort with a protease and polymerase late this year<
I agree. Roche is probably trying to decide whether to start with R1626 or R7128. They would naturally prefer the former but they will probably pick the latter.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”